{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:11:23Z","timestamp":1792131083120,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.tiv.2013.10.013","type":"journal-article","created":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T20:25:39Z","timestamp":1383251139000},"page":"8-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Applying the skin sensitisation adverse outcome pathway (AOP) to quantitative risk assessment"],"prefix":"10.1016","volume":"28","author":[{"given":"Gavin","family":"Maxwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"MacKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cubberley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichola","family":"Gellatly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Glavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Gouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Jacquoilleot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Pendlington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouarda","family":"Saib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sheffield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Summerfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2013.10.013_b0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00204-011-0693-2","article-title":"Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010","volume":"85","author":"Adler","year":"2011","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.tiv.2013.10.013_b0015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1006\/jtbi.2003.3208","article-title":"Models of CD8+ responses: 1. What is the antigen-independent proliferation program","volume":"221","author":"Antia","year":"2003","journal-title":"Journal of Theoretical Biology"},{"key":"10.1016\/j.tiv.2013.10.013_b0020","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/sj.icb.7100050","article-title":"Quantifying HTLV-I dynamics","volume":"85","author":"Asquith","year":"2007","journal-title":"Immunology and Cell Biology"},{"key":"10.1016\/j.tiv.2013.10.013_b0025","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.yrtph.2012.05.013","article-title":"Putting the parts together: combining in vitro methods to test for skin sensitizing potentials","volume":"63","author":"Bauch","year":"2012","journal-title":"Regulatory Toxicology and Pharmacology RTP"},{"key":"10.1016\/j.tiv.2013.10.013_b0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jtbi.2003.12.011","article-title":"A stochastic model of cytotoxic T cell responses","volume":"228","author":"Chao","year":"2004","journal-title":"Journal of Theoretical Biology"},{"key":"10.1016\/j.tiv.2013.10.013_b0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-0536.2009.01657.x","article-title":"Linalool \u2013 a significant contact sensitizer after air exposure","volume":"62","author":"Christensson","year":"2010","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.tiv.2013.10.013_b0040","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/toxsci\/kfq326","article-title":"Determining epidermal disposition kinetics for use in an integrated nonanimal approach to skin sensitization risk assessment","volume":"119","author":"Davies","year":"2011","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.tiv.2013.10.013_b0045","doi-asserted-by":"crossref","first-page":"e41721","DOI":"10.1371\/journal.pone.0041721","article-title":"Elucidation of xenobiotic metabolism pathways in human skin and human skin models by proteomic profiling","volume":"7","author":"van Eijl","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tiv.2013.10.013_b0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1034\/j.1600-0536.2002.470502.x","article-title":"A review of the scientific basis for uncertainty factors for use in quantitative risk assessment for the induction of allergic contact dermatitis","volume":"47","author":"Felter","year":"2003","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.tiv.2013.10.013_b0055","doi-asserted-by":"crossref","first-page":"758","DOI":"10.2174\/138920007782798225","article-title":"Xenobiotic metabolism in human skin and 3D human skin reconstructs: a review","volume":"8","author":"Gibbs","year":"2007","journal-title":"Current Drug Metabolism"},{"key":"10.1016\/j.tiv.2013.10.013_b0060","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.taap.2008.08.014","article-title":"Cytochrome P450-mediated activation of the fragrance compound geraniol forms potent contact allergens","volume":"233","author":"Hagvall","year":"2008","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.tiv.2013.10.013_b0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.14573\/altex.2011.3.211","article-title":"Integrating non-animal test information into an adaptive testing strategy \u2013 skin sensitization proof of concept case","volume":"28","author":"Jaworska","year":"2011","journal-title":"Altex"},{"key":"10.1016\/j.tiv.2013.10.013_b0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/87720","article-title":"Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells","volume":"2","author":"Kaech","year":"2001","journal-title":"Nature Immunology"},{"key":"10.1016\/j.tiv.2013.10.013_b0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1021\/tx7002239","article-title":"Allergic contact dermatitis\u2013formation, structural requirements, and reactivity of skin sensitizers","volume":"21","author":"Karlberg","year":"2008","journal-title":"Chemical Research in Toxicology"},{"key":"10.1016\/j.tiv.2013.10.013_b0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tox.2011.11.007","article-title":"Allergic contact dermatitis: a commentary on the relationship between T lymphocytes and skin sensitising potency","volume":"291","author":"Kimber","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.tiv.2013.10.013_b0085","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.0022-202X.2004.22413.x","article-title":"Molecular size as the main determinant of solute maximum flux across the skin","volume":"122","author":"Magnusson","year":"2004","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.tiv.2013.10.013_b0090","doi-asserted-by":"crossref","first-page":"50","DOI":"10.14573\/altex.2011.1.050","article-title":"Skin sensitisation: the Colipa strategy for developing and evaluating non-animal test methods for risk assessment","volume":"28","author":"Maxwell","year":"2011","journal-title":"Altex"},{"key":"10.1016\/j.tiv.2013.10.013_b0095","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/026119290803600510","article-title":"Application of a systems biology approach to skin allergy risk assessment","volume":"36","author":"Maxwell","year":"2008","journal-title":"Alternatives to Laboratory Animals"},{"key":"10.1016\/j.tiv.2013.10.013_b0100","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1073\/pnas.92.9.3707","article-title":"In vivo estimates of division and death rates of human T lymphocytes","volume":"92","author":"Mclean","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.tiv.2013.10.013_b0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0168-3659(02)00321-8","article-title":"Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways","volume":"86","author":"Mitragotri","year":"2003","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"key":"10.1016\/j.tiv.2013.10.013_b0110","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1440-1711.2003.01191.x","article-title":"Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty","volume":"81","author":"Murray","year":"2003","journal-title":"Immunology and Cell Biology"},{"key":"10.1016\/j.tiv.2013.10.013_b0115","unstructured":"OECD, 2012. The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins. Part 2: Use of the AOP to Develop Chemical Categories and Integrated Assessment and Testing Approaches. Series on Testing and Assessmentp.No. 168. ENV\/JM\/MONO(2012)\/PART2."},{"key":"10.1016\/j.tiv.2013.10.013_b0120","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1103\/RevModPhys.69.1219","article-title":"Immunology for physicists","volume":"69","author":"Perelson","year":"1997","journal-title":"Reviews of Modern Physics"},{"key":"10.1016\/j.tiv.2013.10.013_b0125","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1023\/A:1015810312465","article-title":"Predicting skin permeability","volume":"9","author":"Potts","year":"1992","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.tiv.2013.10.013_b0130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2230.2003.01239.x","article-title":"Contact allergy: the role of skin chemistry and metabolism","volume":"28","author":"Smith Pease","year":"2003","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1016\/j.tiv.2013.10.013_b0135","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1073\/pnas.0709713105","article-title":"Sparse production but preferential incorporation of recently produced naive T cells in the human peripheral pool","volume":"105","author":"Vrisekoop","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.tiv.2013.10.013_b0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni889","article-title":"Lineage relationship and protective immunity of memory CD8 T cell subsets","volume":"4","author":"Wherry","year":"2003","journal-title":"Nature Immunology"}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233313002683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233313002683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T21:08:53Z","timestamp":1564607333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233313002683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0887233313002683"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2013.10.013","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applying the skin sensitisation adverse outcome pathway (AOP) to quantitative risk assessment","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2013.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}